Eurofins Healthcare Assurance expands to China, offering enhanced local support and global expertise in safety and quality ...

Nobel Prize in Chemistry was awarded for AI innovations in protein structure prediction, revolutionising drug development.

Insilico Medicine’s AI-designed drug ISM5939 has received FDA IND clearance for treating solid tumours. By targeting ENPP1, it enhances anti-tumour immunity and is set to begin Phase I trials soon.

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

New study shows E. coli resists antibiotics by modifying its ribosome structure, blocking drug binding and enabling growth despite treatment. The researchers found that, when exposed to antibiotics, E ...

Explore the step-by-step scientific workflow behind drug discovery, from formulating hypotheses to analysing data, ensuring accurate and reliable results. In drug discovery and biological research, ...

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

Halozyme Therapeutics, a biotechnology company based in San Diego, has made a €2 billion offer to acquire Evotec SE, a leading global drug discovery firm. If successful, this acquisition aims to unite ...

Obecabtagene autoleucel (obe-cel) has demonstrated strong efficacy in treating relapsed B-cell leukemia, with high response rates and minimal side effects. The study, published in the New England ...

Viral capsid assembly and quality are key factors in gene therapy success and safety. Here, Dr Chelsea Pratt explores how cutting-edge tools are enabling scientists to tackle these challenges and ...

Find out how Confo Therapeutics is overcoming challenges in GPCR drug development to create next-gen therapies for metabolic diseases.